Trastuzumab in advanced breast cancer – a decade of experience in Germany

door Jackisch, Christian, Schoenegg, Winfried, Reichert, Dietmar, Welslau, Manfred, Selbach, Johannes, Harich, Hanns-Detlev, Tesch, Hans, Wohlfarth, Tim, Eustermann, Heidi, Hinke, Axel
Gepubliceerd in BMC Cancer (2014)

Trastuzumab in Human Epidermal Growth Factor Receptor 2‐Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study on Routine Treatment Between 2006 and 2012 i...

door Dall, Peter, Koch, Thorsten, Göhler, Thomas, Selbach, Johannes, Ammon, Andreas, Eggert, Jochen, Gazawi, Nidal, Rezek, Daniela, Wischnik, Arthur, Hielscher, Carsten, Keitel, Stella, Cirrincione, Ursula, Hinke, Axel, Feisel‐Schwickardi, Gabriele
Gepubliceerd in Oncologist (2017)

Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study

door Dall, Peter, Koch, Thorsten, Göhler, Thomas, Selbach, Johannes, Ammon, Andreas, Eggert, Jochen, Gazawi, Nidal, Rezek, Daniela, Wischnik, Arthur, Hielscher, Carsten, Schleif, Nicolas, Cirrincione, Ursula, Hinke, Axel, Feisel-Schwickardi, Gabriele
Gepubliceerd in BMC Cancer (2018)

Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera

door Schnittger, Susanne, Bacher, Ulrike, Haferlach, Claudia, Geer, Thomas, Müller, Peter, Mittermüller, Johann, Petrides, Petro, Schlag, Rudolf, Sandner, Reiner, Selbach, Johannes, Slawik, Hans Rainer, Tessen, Hans Werner, Wehmeyer, Jürgen, Kern, Wolfgang, Haferlach, Torsten
Gepubliceerd in 2009